Terms: = Ovarian cancer AND GNA11, GNA-11, 2767, ENSG00000088256 AND Diagnosis
4 results:
1. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
Weber-Lassalle N; Borde J; Weber-Lassalle K; Horváth J; Niederacher D; Arnold N; Kaulfuß S; Ernst C; Paul VG; Honisch E; Klaschik K; Volk AE; Kubisch C; Rapp S; Lichey N; Altmüller J; Lepkes L; Pohl-Rescigno E; Thiele H; Nürnberg P; Larsen M; Richters L; Rhiem K; Wappenschmidt B; Engel C; Meindl A; Schmutzler RK; Hahnen E; Hauke J
Breast Cancer Res; 2019 Apr; 21(1):55. PubMed ID: 31036035
[TBL] [Abstract] [Full Text] [Related]
2. Driver pattern identification over the gene co-expression of drug response in ovarian cancer by integrating high throughput genomics data.
Lu X; Lu J; Liao B; Li X; Qian X; Li K
Sci Rep; 2017 Nov; 7(1):16188. PubMed ID: 29170526
[TBL] [Abstract] [Full Text] [Related]
3. Axl molecular targeting counteracts aggressiveness but not platinum-resistance of ovarian carcinoma cells.
Corno C; Gatti L; Arrighetti N; Carenini N; Zaffaroni N; Lanzi C; Perego P
Biochem Pharmacol; 2017 Jul; 136():40-50. PubMed ID: 28404378
[TBL] [Abstract] [Full Text] [Related]
4. Proportion of gynecologic cancer patients using complementary and alternative medicine.
Supoken A; Chaisrisawatsuk T; Chumworathayi B
Asian Pac J Cancer Prev; 2009; 10(5):779-82. PubMed ID: 20104968
[TBL] [Abstract] [Full Text] [Related]
